BaselArea.swiss welcomes BeiGene to Basel
BeiGene, Ltd., a global commercial-stage biopharmaceutical company, has established a regional headquarters in Basel. BaselArea.swiss assisted BeiGene in evaluating and establishing the new site.
BeiGene in Basel
The Nasdaq and Hong Kong Stock Exchange-listed company is dedicated to becoming a global leader in the discovery, development and commercialization of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer.
From its new location in Basel, BeiGene will manage its European clinical trial operations and prepare for the potential launch of its drug candidates outside of Asia. The new presence marks another milestone for BeiGene on its way to becoming a leading global bio-pharma company.
Access to a large and highly skilled talent pool, a business-friendly environment and close proximity to the European market were key drivers of BeiGene’s decision to establish operations in Basel. Basel is home to several of the world’s leading oncology companies and a vibrant biotech hub. Many global life sciences companies manage their commercial activities from Basel.
BeiGene has a global team of over 1,300 employees, including more than 500 people in its clinical team in China, the United States and Australia. The company has offices in China in Beijing, Guangzhou, Shanghai and Suzhou; in the United States in Cambridge, MA, Ridgefield Park, NJ, and Emeryville and San Mateo, CA; and in Europe in Basel, Switzerland.
Share this article
Share this article
You might also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.Read More